FDA official logo
GSRS logo
PFDA official logo

CAFFEINE

  • UNII: 3G6A5W338E
  • Formula: C8H10N4O2
  • Preferred Substance Name: CAFFEINE
  • InChIKey: RYYVLZVUVIJVGH-UHFFFAOYSA-N

  • 58-08-2
  • 200-362-1
  • 1,3,7-TRIMETHYLXANTHINE
  • 1H-PURINE-2,6-DIONE, 3,7-DIHYDRO-1,3,7-TRIMETHYL-
  • ANHYDROUS CAFFEINE
  • ANHYDROUS CAFFEINE [JAN]
  • ANOQUAN COMPONENT CAFFEINE
  • CAFERGOT COMPONENT CAFFEINE
  • CAFFEINE [EP MONOGRAPH]
  • CAFFEINE [FCC]
  • CAFFEINE [FHFI]
  • CAFFEINE [HSDB]
  • CAFFEINE [IARC]
  • CAFFEINE [II]
  • CAFFEINE [MART.]
  • CAFFEINE [MI]
  • CAFFEINE [ORANGE BOOK]
  • CAFFEINE [USP MONOGRAPH]
  • CAFFEINE [USP-RS]
  • CAFFEINE [VANDF]
  • CAFFEINE [WHO-DD]
  • CAFFEINE [WHO-IP]
  • CAFFEINE ANHYDROUS [WHO-IP]
  • CAFFEINE MELTING POINT STANDARD
  • CAFFEINUM
  • CAFFEINUM [HPUS]
  • COFFEINUM [WHO-IP LATIN]
  • DARVON COMPOUND COMPONENT CAFFEINE
  • DHC PLUS COMPONENT CAFFEINE
  • DIMENHYDRINATE IMPURITY C
  • DIMENHYDRINATE IMPURITY C [EP IMPURITY]
  • DURVITAN
  • ESGIC COMPONENT CAFFEINE
  • EXCEDRIN COMPONENT CAFFEINE
  • FEMA NO. 2224
  • FEMCET COMPONENT CAFFEINE
  • FIORICET COMPONENT CAFFEINE
  • FIORINAL COMPONENT CAFFEINE
  • GUARANINE
  • INVAGESIC COMPONENT CAFFEINE
  • INVAGESIC FORTE COMPONENT CAFFEINE
  • LANORINAL COMPONENT CAFFEINE
  • MEDIGESIC PLUS COMPONENT CAFFEINE
  • METHYLTHEOBROMINE
  • MIGERGOT COMPONENT CAFFEINE
  • NORGESIC COMPONENT CAFFEINE
  • NSC-5036
  • ORPHENGESIC COMPONENT CAFFEINE
  • ORPHENGESIC FORTE COMPONENT CAFFEINE
  • PENTOXIFYLLINE IMPURITY F [EP IMPURITY]
  • SYNALGOS
  • SYNALGOS-DC COMPONENT CAFFEINE
  • SYNALGOS-DC-A COMPONENT CAFFEINE
  • THEINE
  • THEOPHYLLINE IMPURITY A [EP IMPURITY]
  • THEOPHYLLINE MONOHYDRATE IMPURITY A [EP IMPURITY]
  • TREZIX COMPONENT CAFFEINE
  • TRIAD COMPONENT CAFFEINE
  • VIVARIN
  • WIGRAINE COMPONENT CAFFEINE

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.